Cytopathology

Lung cancers metabolise differently

Researchers have discovered that the two most common forms of lung cancer metabolise nutrients differently, revealing new vulnerabilities that could be exploited in future treatment for patients.

Biomarker for bladder cancer

A new diagnostic technique has revealed a protein biomarker that accurately differentiates bladder cancer from benign inflammation.

A cellular intranet

Professor Mark Evans explains his research into cellular networks that can be rapidly dismantled, reconfigured and rebuilt.

War on cancer pt. 3

The final instalment of a short series, which briefly reviews the historical developments in cancer treatment, covering recent approaches, such as targeted therapy and genetic profiling. 

Q&A Professor Robert Langer

Professor Robert Langer, Institute Professor at the Massachusetts Institute of Technology (MIT) and a scientist, entrepreneur and inventor, discusses his research, advances in cancer treatment, biomaterials and slow-release medicines.

May journal-based learning exercises

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

War on cancer pt.2: landmarks in the development of chemotherapy

The second article of two, which briefly reviews the historical developments and use of chemotherapy since 1948 to treat different cancers. 
 

April: News in numbers

A breakdown of science news this month, in numbers.

Liquid biopsy for non-small cell lung cancer

A US multi-centre study revealed that a liquid biopsy is comparable to standard tissue biopsies in detection of guideline recommended biomarkers in advanced non-small cell lung cancer (NSCLC).

War on cancer PT 1: the development of chemotherapy to 1950

A review of the early historical development and use of chemotherapy to treat different cancers. The phrase “war on cancer” refers to the recognition of cancer as a major cause of death and the need to act, resulting in increased funding, clinical trials and the development of more effective treatments.

3D human cell models

Medicines Discovery Catapult and the Medical Research Council Centre for Drug Safety Science at the University of Liverpool are collaborating.

Top